Literature DB >> 15223269

Change in the expression of NPY receptor subtypes Y1 and Y2 in central and peripheral neurons related to the control of blood pressure in rats following experimental hypertension.

E F Coelho1, M F R Ferrari, J R Maximino, D R Fior-Chadi.   

Abstract

Neuropeptide Y (NPY) is known to participate in central mechanisms of blood pressure control. However, variations on the expression of its receptors in response to a hypertensive challenge are not well defined, specially when considering that Y1 and Y2 often mediate opposite responses. In this study we have employed in situ hybridization to analyze changes in mRNA expression of NPY receptor subtypes Y1 and Y2 in the nucleus tractus solitarii (NTS), paraventricular nucleus of the hypothalamus (PVN) and petrosal and nodose ganglions 2 h, 3 and 7 days after aortic coarctation induced hypertension. Quantification by image analysis showed significant differences between sham-operated and aortic-coarcted hypertensive rats. Y1 receptor mRNA expression was increased (39%) in petrosal ganglion, 3 days after surgery. Y2 receptor mRNA expression was increased (143%) in the NTS of hypertensive compared with sham rats 2 h after surgery. Y2 receptor mRNA was decreased (62%) in the nodose ganglion of hypertensive compared with sham rats 2 h after surgery. No change was seen in Y1 and Y2 mRNA expression in the PVN in any analyzed period. The data suggest that NPY Y1 and Y2 receptors might participate in the mechanisms involved in the establishment/maintenance of hypertension induced by aortic coarctation. Acute changes seem to be involved with the adaptation to the new hypertensive state.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15223269     DOI: 10.1016/j.npep.2004.03.001

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  Polymorphisms in LEP and NPY genes modify the response to soluble fibre Plantago ovata husk intake on cardiovascular risk biomarkers.

Authors:  Anna Crescenti; Rosa Solà; Rosa M Valls; Anna Anguera; Lluís Arola
Journal:  Genes Nutr       Date:  2012-06-06       Impact factor: 5.523

2.  Inhibitory effect of D1-like dopamine receptors on neuropeptide Y-induced proliferation in vascular smooth muscle cells.

Authors:  Yongqiao Zhou; Weibin Shi; Hao Luo; Rongchuan Yue; Zhen Wang; Wei Wang; Li Liu; Wei Eric Wang; Hongyong Wang; Chunyu Zeng
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

3.  Placental Neuropeptide Y ( NPY) and NPY receptors expressions and serum NPY levels in preeclampsia.

Authors:  Roongrit Klinjampa; Chantacha Sitticharoon; Xaynaly Souvannavong-Vilivong; Chanakarn Sripong; Issarawan Keadkraichaiwat; Malika Churintaraphan; Saimai Chatree; Tripop Lertbunnaphong
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-13

4.  Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.

Authors:  Kathryn A Gradin; Carsten L Buus; Jia-Yi Li; Ole Frøbert; Ulf Simonsen
Journal:  Br J Pharmacol       Date:  2006-05-22       Impact factor: 8.739

5.  Plasma neuropeptide Y (NPY) and alpha-melanocyte stimulating hormone (a-MSH) levels in patients with or without hypertension and/or obesity: a pilot study.

Authors:  Maria Baltazi; Niki Katsiki; Christos Savopoulos; Fotios Iliadis; George Koliakos; Apostolos I Hatzitolios
Journal:  Am J Cardiovasc Dis       Date:  2011-05-20

6.  Neuropeptide Y promoter polymorphism modifies effects of a weight-loss diet on 2-year changes of blood pressure: the preventing overweight using novel dietary strategies trial.

Authors:  Xiaomin Zhang; Qibin Qi; Jun Liang; Frank B Hu; Frank M Sacks; Lu Qi
Journal:  Hypertension       Date:  2012-09-10       Impact factor: 10.190

7.  Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis.

Authors:  Brandon T Milliken; Clinton Elfers; Oleg G Chepurny; Kylie S Chichura; Ian R Sweet; Tito Borner; Matthew R Hayes; Bart C De Jonghe; George G Holz; Christian L Roth; Robert P Doyle
Journal:  J Med Chem       Date:  2021-01-15       Impact factor: 7.446

8.  Neuropeptide Y-mediated sex- and afferent-specific neurotransmissions contribute to sexual dimorphism of baroreflex afferent function.

Authors:  Yang Liu; Di Wu; Mei-Yu Qu; Jian-Li He; Mei Yuan; Miao Zhao; Jian-Xin Wang; Jian He; Lu-Qi Wang; Xin-Jing Guo; Meng Zuo; Shu-Yang Zhao; Mei-Na Ma; Jun-Nan Li; Weinian Shou; Guo-Fen Qiao; Bai-Yan Li
Journal:  Oncotarget       Date:  2016-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.